Synthesis and application of Au NPs-chitosan nanocomposite in the treatment of acute myeloid leukemia in vitro and in vivo

Nano CaCO3 mediated in vitro and in vivo wound healing characteristics of chitosan films without added drugs

The proposed investigation aims towards introducing a facile and cost-effective chitosan-based material for healing of full thickness wounds via stimulation of keratinocyte at wound junction to yield faster closure. Chitosan (CS) crosslinked polyacrylic acid (PAA) polymeric networks are chosen as the matrix element to incorporate gold nanoparticles (Au Nps) and nano calcium carbonate (CaCO3 Nps) via covalent and electrostatic interactions. The as-synthesized CS/PAA@Au/CaCO3 nanocomposite hydrogels reveal high in vitro and in vivo biocompatibility against human kidney epithelial (HKE) cells and drosophila larvae, with minimum cell viability of 88.45 % at high doses of 87.5 μg/μL. The innate pH responsive swelling behaviour (1450 %) and WVTR (8.451 mg·cm-2·h-1), hemocompatibility, bioadhesivity along with antibacterial and anti-biofilm activity of the nanocomposite hydrogels against S. aureus and E. coli provide prior motivation to escalate the study towards in vivo wound healing in invertebrates (D.melanogaster) and vertebrates (Sprague-Dawley rats). The proposed hydrogels show accelerated healing in invertebrates and vertebrates, i.e., complete recovery in 3 h and 11 days, respectively. The histopathology analysis establishes the deposition of highly aligned collagen fibers on the wound surface supported by the tight keratinocyte junction at wound surface by the action of calcium ions for which the material becomes promising for wound healing applications.

Targeted therapy for leukemia based on nanomaterials

Leukemia is a kind of hematopoietic stem cell malignant clonal disease. Drug therapy is the core treatment strategy for leukemia, but the current therapeutic drugs have defects such as low bioavailability, large adverse reactions and inconvenient intravenous administration. Targeted therapy can combine drugs with specific carcinogenic sites on cells to kill cancer cells and avoid damage to normal cells, which has gradually become the mainstream method of leukemia treatment. In addition, nanomedicine delivery systems can significantly improve drug efficacy through controlled size and targeted optimization of drug delivery by modification strategies. Therefore, the targeted treatment of leukemia based on nanomaterials has great research value and application prospect. This paper gives an overview of the current therapeutic strategies for leukemia, and then reviews the cutting-edge targeted therapeutic nanomaterials for leukemia, including organic nanomaterials (mainly carbon-based nanomaterials, lipid materials, polymers, etc.) and inorganic nanomaterials (mainly noble metal nanoparticles, magnetic nanoparticles, hollow mesoporous materials, etc.). The challenges and prospects for the future development of targeted nanomaterials in the treatment of leukemia are also briefly reviewed.